Emergent BioSolutions EBS
NYSE EBS
$6.04 -0.06 (-0.98%)
As of: Nov 10, 2026 · 3:59 PM EST

Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026)

Updated

Analysis

Emergent BioSolutions (EBS) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 15.10 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.42 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.90 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 10.02 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn 10.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10.90 Mn
Jun 30, 2026 12.20 Mn
Mar 31, 2026 14.20 Mn
Dec 31, 2025 14.20 Mn
Sep 30, 2025 15.30 Mn
Jun 30, 2025 3.70 Mn
Mar 31, 2025 3.70 Mn
Dec 31, 2024 25.00 Mn
Sep 30, 2024 6.50 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 500,000.00
Sep 30, 2022 40.80 Mn
Jun 30, 2022 51.30 Mn
Mar 31, 2022 57.10 Mn
Dec 31, 2021 58.20 Mn
Sep 30, 2021 102.20 Mn
Jun 30, 2021 109.90 Mn
Mar 31, 2021 111.40 Mn
Dec 31, 2020 113.40 Mn
Sep 30, 2020 106.40 Mn
API Access

Emergent BioSolutions Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EBS&period=max&api_key=YOUR_API_KEY